Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Canopy Growth

Both pot companies' recent quarterly results were bleak, but one has a better chance to rebound.

Better Buy: Aurora Cannabis vs. Canopy Growth

OrganiGram Holdings Inc.

SNDL Inc.

Tilray Brands

There's a promising development in one U.S. state.

Why Marijuana Stocks Like Aurora Cannabis Rose So Much Today

And why it's pulling up Canopy Growth and Tilray marijuana stocks alongside it.

Why Aurora Cannabis Stock Is Popping Today

CEA Industries

HEXO Corp

Leafly Holdings

WM Technology

Neptune Wellness Solutions Inc.

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

Catch Up On the Busiest Week For Cannabis Stocks of 2022

Cantor Fitzgerald analyst Pablo Zuanic on Friday reiterated a neutral rating on Aurora Cannabis ACB, -1.08% ACB, -1.02% and cut his 12-month price target to C$7.60 from C$10.75 due to reduced sales estimates. The company said it expects to reach positive Ebitda by the first half of fiscal year 2023, but Zuanic said the company remains a long-term turnaround story.

Cantor Fitzgerald cuts price target on Aurora Cannabis

Aurora Cannabis Inc. (ACB) CEO Miguel Martin on Q2 2022 Results - Earnings Call Transcript

Aurora Cannabis  ACB ACB announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021. "During the second quarter, we improved our Adjusted EBITDA by $2.5 million over Q1, moving us closer to our profitability goal.

Aurora Cannabis Reports $75.1M Q2 Loss As Revenues Fall By 10 Percent

Aurora Cannabis Inc (NASDAQ: ACB) is up 10% after-hours on better-than-expected sales for the fiscal second quarter. It's the first time in over a year that the cannabis company topped sales estimates.

Aurora Cannabis CEO: ‘our transformation plan is on track'

Aurora Cannabis Inc. shares gained in late trading Thursday, after the Canadian pot producer beat sales expectations for the first time in more than a year.

Aurora Cannabis stock gains after first beat on pot sales in more than a year

Global Cannabis Net Revenue of $60.6 Million Adjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022 Company Reaffirms Goal of Adjusted EBITDA Profitability by H1/2023 Transformation Plan Ahead of Schedule; Company Now Expects to Realize Upper End of $60 to $80 Million Range in Total Cost Savings by H1/2023; ~$60 Million Annualized Savings Implemented to Date Company Remains #1 Canadian LP in Global Medical Cannabis; International Cannabis Revenue Increased 24% from Q1 2022 NASDAQ | TSX: ACB EDMONTON, AB, Feb. 10, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021. "During the second quarter, we improved our Adjusted EBITDA by $2.5 million over Q1, moving us closer to our profitability goal.

Aurora Cannabis Announces Fiscal 2022 Second Quarter Results

Cannabis stocks are up today as some companies report earnings. Sundial Growers has its own cause to celebrate as its story continues.

Cannabis Stocks Alert: Why Are SNDL, CGC, TLRY, ACB Stocks Are Getting High Today?

Affirm

Cloudflare

Zillow

Markets closed higher on Tuesday, primarily due to some buying action in the final hour of trading.

Earnings Previews: Affirm, Aurora Cannabis, Cloudflare, Zillow

Canopy Growth reported better-than-expected overall revenue in its most recent quarter.

Why Canopy Growth, Sundial Growers, and Aurora Cannabis Stocks Jumped Today

Aurora Cannabis Inc. and Canopy Growth Corp. are expected to remain in the red but trim their losses when they release financial results later this week, as they face a sluggish legal cannabis market in Canada.

Cannabis Watch: Canopy Growth and Aurora Cannabis are expected to generate less red ink when they report earnings this week

Aurora Cannabis Inc. (ACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aurora Cannabis Inc. (ACB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Cronos Group

Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.

Cannabis Watch: Cannabis companies pivot to debt to raise capital as stock prices lag

CBD brand and subsidiary of Canadian cannabis giant Aurora Cannabis Inc. ACB ACB, Reliva,   announced the launch of KG7, a new high-quality CBD product line developed for adult consumers with an active lifestyle. KG7 and Reliva products are available for purchase online and in convenience stores across the United States.

Aurora Cannabis' Reliva Expands Portfolio With New CBD Brand, KG7

NASDAQ | TSX: ACB Sports-oriented KG7 now available at relivacbd.com and in convenience stores across the U.S. EDMONTON, AB, Feb. 3, 2022 /PRNewswire/ - Reliva, a leading American CBD brand and subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the launch of KG7, a new high-quality CBD product line developed for adult consumers with an active lifestyle. KG7 and Reliva products are available for purchase at https://relivacbd.com/ and in convenience stores across the United States.

Aurora Cannabis's Reliva Expands Portfolio with New CBD Brand, KG7

The company's bottom line has been trending in the right direction of late.

Should Investors Expect Aurora Cannabis to Post a Profit in Q2?

Marijuana banking legislation advances in the House. But will it make a difference?

Why Marijuana Stocks Hit a Pot-Hole Today

Top Canadian Pot Stocks To Watch In February The post Top Canadian Marijuana Stocks On The Nasdaq In 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks On The Nasdaq In 2022

Aurora Cannabis Inc. ACB ACB announced a scheduled conference call to discuss the results for its second-quarter fiscal year 2022 on Thursday, February 10, 2022 at 5:00 p.m. ET. The Company will report its financial results for the second quarter fiscal year 2022 after the close of markets that same day.

Aurora Cannabis To Host Q2 Fiscal Year 2022 Investor Conference Call

NASDAQ | TSX: ACB EDMONTON, AB , Feb. 1, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2022 on Thursday, February 10, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m.

Aurora Cannabis to Host Second Quarter Fiscal Year 2022 Investor Conference Call

Sen. Schumer signals a willingness to let marijuana banking reform proceed.

Why Marijuana Stocks Are Smoking Hot Today

Cannabis industry expert Alan Brochstein on 2022 catalysts.

News for Aurora Cannabis Stock (ACB)